"The increasing expenses associated with bladder cancer treatment highlight wider issues regarding the sustainability of health care expenditures in the US," writes Michael S. Cookson, MD, MMHC, FACS.
(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on optimizing treatment for your patient with urothelial cancer, and a presentation by Dr. Brent ...
DART showed safety and efficacy in MIBC, with acceptable toxicity and promising tumor control, comparable to cystectomy outcomes. The RAIDER trial enrolled 345 patients, comparing DART, WBRT, and SART ...
Urinary incontinence, or leakage of urine, is a very common condition for women of all ages, ethnicities and backgrounds. Urine leaks may be as small as a drop, or it may be a flow of urine that can't ...
Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...
“A UTI isn’t treated with dietary changes,” says Philippe E. Zimmern, MD, director of the Cain Bladder Center at UT Southwestern Medical Center in Dallas. “That means following your doctor ...
Johnson & Johnson has initiated an application seeking Food and Drug Administration approval of its TAR-200 drug-device combination for the treatment of certain patients with bladder cancer.
Incontinence is one of the more common problems I see in my clinic. And, in many cases, it's due to a condition called overactive bladder syndrome, which leaves patients constantly needing the loo.